Full Press Release Details
Immutep to Participate in November Investor Events.
IMMP
Immutep to Participate in November Investor Events
Key Takeaway: Immutep to Participate in November Investor Events
Price reaction · baseline $1.89 (2023-10-31 close) · hit after-hours · 4 other IMMP headline(s) in the window, move may be shared
day 0 close
-1.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+76%
120-day peak, hindsight
Typical move
5.4%
average across 13 past catalysts
Lead asset
eftilagimod alfa
Phase 3 · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)